Publications from the Massey Cancer Center, Virginia Commonwealth University.

Follow

Submissions from 2017

PDF

Sequence homology between HLA-bound cytomegalovirus and human peptides: A potential trigger for alloreactivity, Charles E. Hall, Vishal N. Koparde, Maximilian Jameson-Lee, Abdelrhman G. Elnasseh, Allison F. Scalora, David J. Kobulnicky, Myrna G. Serrano, Catherine H. Roberts, Gregory A. Buck, Michael C. Neale, Daniel E. Nixon, and Amir A. Toor

PDF

Epirubicin With Cyclophosphamide Followed by Docetaxel With Trastuzumab and Bevacizumab as Neoadjuvant Therapy for HER2-Positive Locally Advanced Breast Cancer or as Adjuvant Therapy for HER2-Positive Pathologic Stage III Breast Cancer: A Phase II Trial of the NSABP Foundation Research Group, FB-5, John W. Smith, Marc E. Buyse, Priya Rastogi, Charles E. Geyer Jr., Samuel A. Jacobs, Erica J. Patocskai, André Robidoux, Alison K. Conlin, Bilal Ansari, George P. Keogh, Philip J. Stella, Howard M. Gross, Raymond S. Lord, Jonathan A. Polikoff, Celine Mauquoi, Eleftherios P. Mamounas, Sandra M. Swain, and Norman Wolmark

Submissions from 2016

PDF

Tumor-reactive immune cells protect against metastatic tumor and induce immunoediting of indolent but not quiescent tumor cells, Kyle K. Payne, Rebecca Keim, Laura Graham, Michael O. Idowu, Wen Wan, Xiang-Yang Wang, Amir A. Toor, Harry D. Bear, and Masoud H. Manjili

Submissions from 2015

PDF

Epigenetic Modifications of the PGC-1α Promoter during Exercise Induced Expression in Mice, Timothy L. Lochmann, Ravindar R. Thomas, James P. Bennett, and Shirley M. Taylor

Submissions from 2014

PDF

Job attributes, job satisfaction and the return to health after breast cancer diagnosis and treatment, Andrew J. Barnes, Nicholas Robert, and Cathy J. Bradley

PDF

Inhibition of the MDM2 E3 Ligase Induces Apoptosis and Autophagy in Wild-Type and Mutant p53 Models of Multiple Myeloma, and Acts Synergistically with ABT-737, Dongmin Gu, Shuhong Wang, Isere Kuiatse, Hua Wang, Jin He, Yun Dai, Richard J. Jones, Chad C. Bjorklund, Jing Yang, Steven Grant, and Robert Z. Orlowski

PDF

Adjuvant Exemestane with Ovarian Suppression in Premenopausal Breast Cancer, Olivia Pagani, Meredith M. Regan, Barbara A. Walley, Gini F. Fleming, Marco Colleoni, István Láng, Henry L. Gomez, Carlo Tondini, Harold J. Burstein, Edith A. Perez, Eva Ciruelos, Vered Stearns, Hervé R. Bonnefoi, Silvana Martino, Charles E. Geyer Jr., Graziella Pinotti, Fabio Puglisi, Diana Crivellari, Thomas Ruhstaller, Eric P. Winer, Manuela Rabaglio-Poretti, Rudolf Maibach, Barbara Ruepp, Anita Giobbie-Hurder, Karen N. Price, Jürg Bernhard, Weixiu Luo, Karin Ribi, Giuseppe Viale, Alan S. Coates, Richard D. Gelber, Aron Goldhirsch, and Prudence A. Francis

PDF

Circumvention of Mcl-1-Dependent Drug Resistance by Simultaneous Chk1 and MEK1/2 Inhibition in Human Multiple Myeloma Cells, Xin-Yan Pei, Yun Dai, Jessica Felthousen, Shuang Shen, Yukie Takabatake, Liang Zhou, Leena E. Youssefian, Michael W. Sanderson, Wesley W. Bodie, Lora B. Kramer, Robert Z. Orlowski, and Steven Grant

PDF

Live Cell Interferometry Quantifies Dynamics of Biomass Partitioning during Cytokinesis, Thomas A. Zangle, Michael A. Teitell, and Jason Reed

Submissions from 2013

PDF

Peripheral blood mononuclear cells of breast cancer patients can be reprogrammed to enhance anti-HER-2/neu reactivity and overcome myeloid-derived suppressor cells [poster abstract], Kyle K. Payne, Christine K. Zoon, Wen Wan, Khin Marlar, Rebecca C. Keim, Mehrab Nasirir Kenari, Latif Kazim, Harry D. Bear, and Masoud H. Manjili

Submissions from 2012

PDF

Peripheral-Blood Stem Cells versus Bone Marrow from Unrelated Donors, Claudio Anasetti, Brent R. Logan, Stephanie J. Lee, Edmund K. Waller, Daniel J. Weisdorf, John R. Wingard, Corey S. Cutler, Peter Westervelt, Ann Woolfrey, Stephen Couban, Gerhard Ehninger, Laura Johnston, Richard T. Maziarz, Michael A. Pulsipher, David L. Porter, Shin Mineishi, John M. McCarty, Shakila P. Khan, Paolo Anderlini, William I. Bensinger, Susan F. Leitman, Scott D. Rowley, Christopher Bredeson, Shelly L. Carter, Mary M. Horowitz, and Dennis L. Confer

PDF

Bevacizumab Added to Neoadjuvant Chemotherapy for Breast Cancer, Harry D. Bear, Gong Tang, Priya Rastogi, Charles E. Geyer Jr., Andre Robidoux, James N. Atkins, Luis Baez-Diaz, Adam M. Brufsky, Rita S. Mehta, Louis Fehrenbacher, James A. Young, Francis M. Senecal, Rakesh Gaur, Richard G. Margolese, Paul T. Adams, Howard M. Gross, Joseph P. Costantino, Sandra M. Swain, Eleftherios P. Mamounas, and Norman Wolmark

Submissions from 2000

PDF

Development of a high throughput, molecular diagnostic assay for predicting telomerase activity in breast cancer cell lines and tissues, L. Elmore, A. Akalin, L. Gollahon, G. Clarke, M. Grimes, A. Ferreira-Gonzalez, C. Garrett, and S. Holt

Submissions from 1991

PDF

Efficacy and Cost Effectiveness of Adjuvant Chemotherapy in Women with Node-Negative Breast Cancer — A Decision-Analysis Model, Bruce E. Hillner , M.D. and Thomas J. Smith , M.D.